Susquehanna Fundamental Investments, LLC Annexon, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 119,725 shares of ANNX stock, worth $365,161. This represents 0.01% of its overall portfolio holdings.
Number of Shares
119,725
Previous 163,025
26.56%
Holding current value
$365,161
Previous $799 Million
99.92%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ANNX
# of Institutions
159Shares Held
100MCall Options Held
171KPut Options Held
131K-
Satter Management Co., L.P.7.41MShares$22.6 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$21.4 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$20.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$19.2 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$17.2 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $145M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...